Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-13 Sale | 2024-06-17 7:35 pm | uniQure N.V. | QURE | Meek David D. Director | 2,229 | $5.12 | $11,412 | 20,252 (Direct) | View |
| 2023-06-16 Sale | 2023-06-20 5:25 pm | uniQure N.V. | QURE | Meek David D. Director | 2,290 | $18.85 | $43,167 | 39,541 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:09 pm | uniQure N.V. | QURE | Meek David D. Director | 389 | $19.71 | $7,667 | 16,071 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 09:45 am | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 3,179 | $42.38 | $134,715 | 61,792 (Direct) | View |
| 2022-12-21 Sale | 2022-12-21 9:20 pm | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 4,616 | $40.41 | $186,552 | 64,971 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 5:34 pm | uniQure N.V. | QURE | Meek David D. Director | 602 | $16.7 | $10,053 | 7,380 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 1:58 pm | uniQure N.V. | QURE | Meek David D. Director | 505 | $37.5 | $18,938 | 6,448 (Direct) | View |
| 2020-01-28 Sale | 2020-01-30 8:54 pm | uniQure N.V. | QURE | Meek David D. Director | 722 | $62.19 | $44,903 | 2,508 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-19 Option Award | 2024-06-21 5:10 pm | N/A 2034-06-19 | uniQure N.V. | QURE | Meek David D. Director | 23,920 | $0 | 44,172 (Direct) | View |
| 2024-06-04 Disposition | 2024-06-04 5:25 pm | N/A N/A | Fusion Pharmaceuticals Inc. | FUSN | Meek David D. Director | 34,000 | $0 | 0 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-16 5:40 pm | N/A 2034-05-15 | Cullinan Therapeutics Inc. | CGEM | Meek David D. Director | 15,618 | $0 | 15,618 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-16 5:00 pm | N/A 2033-10-16 | Fusion Pharmaceuticals Inc. | FUSN | Meek David D. Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-20 5:25 pm | N/A 2033-06-13 | uniQure N.V. | QURE | Meek David D. Director | 25,760 | $0 | 39,541 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 240,612 | $0 | 302,404 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 9:20 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 35,425 | $0 | 64,971 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:07 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 27,500 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:07 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 28,307 | $0 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:07 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 22,000 | $2.2 | 0 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:22 pm | N/A 2032-06-15 | uniQure N.V. | QURE | Meek David D. Director | 26,890 | $0 | 34,270 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 6:27 pm | N/A 2032-02-24 | uniQure N.V. | QURE | Meek David D. Director | 4,179 | $0 | 10,627 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:02 pm | N/A 2029-06-18 | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 22,500 | $0 | 17,307 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:02 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 17,307 | $0 | 17,307 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:01 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 27,500 | $0 | 49,500 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-18 6:20 pm | N/A 2032-01-13 | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 90,490 | $0 | 90,490 (Direct) | View |
| 2021-09-22 Option Award | 2021-09-24 5:11 pm | N/A 2031-09-21 | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 150,300 | $0 | 150,300 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 10:34 am | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 4:00 pm | N/A 2031-02-25 | uniQure N.V. | QURE | Meek David D. Director | 6,489 | $0 | 11,060 (Direct) | View |
| 2020-06-10 Option Award | 2020-10-06 4:33 pm | N/A 2030-06-09 | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 11,000 | $0 | 11,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 3:54 pm | N/A 2030-02-27 | uniQure N.V. | QURE | Meek David D. Director | 5,683 | $0 | 8,191 (Direct) | View |